KINGDON CAPITAL MANAGEMENT, L.L.C. - Q4 2015 holdings

$2.06 Billion is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 114 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .

 Value Shares↓ Weighting
GOOGL NewALPHABET INCcap stk cl a$80,431,000103,380
+100.0%
3.91%
IBB NewISHARES TRput$50,750,000150,000
+100.0%
2.47%
HYG NewISHARES TRcall$48,348,000600,000
+100.0%
2.35%
QQQ NewPOWERSHARES QQQ TRUSTput$43,625,000390,000
+100.0%
2.12%
AA NewALCOA INC$31,696,0003,211,331
+100.0%
1.54%
MJN NewMEAD JOHNSON NUTRITION COcall$31,580,000400,000
+100.0%
1.54%
DAL NewDELTA AIR LINES INC DEL$30,048,000592,770
+100.0%
1.46%
AIGWS NewAMERICAN INTL GROUP INC*w exp 01/19/202$27,360,000441,501
+100.0%
1.33%
SBGI NewSINCLAIR BROADCAST GROUP INCcl a$20,888,000641,927
+100.0%
1.02%
NewTEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0$20,347,00020,000
+100.0%
0.99%
UUP NewPOWERSHS DB US DOLLAR INDEXput$19,238,000750,000
+100.0%
0.94%
SYF NewSYNCHRONY FINL$18,930,000622,501
+100.0%
0.92%
AGN NewALLERGAN PLCcall$18,750,00060,000
+100.0%
0.91%
ESRX NewEXPRESS SCRIPTS HLDG COput$17,482,000200,000
+100.0%
0.85%
JNK NewSPDR SERIES TRUSTcall$16,955,000500,000
+100.0%
0.82%
ALKS NewALKERMES PLCcall$15,876,000200,000
+100.0%
0.77%
MLNX NewMELLANOX TECHNOLOGIES LTD$15,822,000375,462
+100.0%
0.77%
CCE NewCOCA COLA ENTERPRISES INC NE$15,280,000310,325
+100.0%
0.74%
CSRA NewCSRA INC$15,153,000505,107
+100.0%
0.74%
ALKS NewALKERMES PLCput$11,812,000148,800
+100.0%
0.57%
MCD NewMCDONALDS CORP$11,490,00097,256
+100.0%
0.56%
NewANACOR PHARMACEUTICALS INCnote 2.000%10/1$11,472,0003,151,000
+100.0%
0.56%
LSCC NewLATTICE SEMICONDUCTOR CORP$10,370,0001,602,722
+100.0%
0.50%
PFE NewPFIZER INCcall$9,684,000300,000
+100.0%
0.47%
DVAX NewDYNAVAX TECHNOLOGIES CORPcall$9,664,000400,000
+100.0%
0.47%
GPK NewGRAPHIC PACKAGING HLDG COcall$9,623,000750,000
+100.0%
0.47%
LRCX NewLAM RESEARCH CORP$8,804,000110,855
+100.0%
0.43%
NewLAM RESEARCH CORPnote 0.500% 5/1$8,430,0006,500,000
+100.0%
0.41%
BWLD NewBUFFALO WILD WINGS INC$8,190,00051,300
+100.0%
0.40%
NKE NewNIKE INCcl b$7,375,000118,000
+100.0%
0.36%
CWEI NewWILLIAMS CLAYTON ENERGY INC$7,097,000240,000
+100.0%
0.34%
CL NewCOLGATE PALMOLIVE COcall$6,662,000100,000
+100.0%
0.32%
SIMO NewSILICON MOTION TECHNOLOGY COsponsored adr$6,117,000195,070
+100.0%
0.30%
ZION NewZIONS BANCORPORATION$5,760,000211,000
+100.0%
0.28%
EAT NewBRINKER INTL INC$5,411,000112,841
+100.0%
0.26%
NXST NewNEXSTAR BROADCASTING GROUP Icl a$4,784,00081,502
+100.0%
0.23%
EPC NewEDGEWELL PERS CARE CO$4,557,00058,151
+100.0%
0.22%
KHC NewKRAFT HEINZ CO$3,638,00050,000
+100.0%
0.18%
CVS NewCVS HEALTH CORP$3,599,00036,815
+100.0%
0.18%
CAFD New8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$3,551,000220,000
+100.0%
0.17%
MBBYF NewMOBILEYE N V AMSTELVEEN$3,382,00080,000
+100.0%
0.16%
ENTA NewENANTA PHARMACEUTICALS INCput$3,302,000100,000
+100.0%
0.16%
ZLTQ NewZELTIQ AESTHETICS INC$2,853,000100,000
+100.0%
0.14%
CSAL NewCOMMUNICATIONS SALES&LEAS IN$2,804,000150,000
+100.0%
0.14%
RDWR NewRADWARE LTDord$2,361,000153,900
+100.0%
0.12%
WWAV NewWHITEWAVE FOODS CO$1,957,00050,300
+100.0%
0.10%
CEMP NewCEMPRA INCcall$778,00025,000
+100.0%
0.04%
CMRX NewCHIMERIX INCcall$118,00013,200
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings